Deconditioning in Transplant

Effect of Increased Activity on Deconditioning in Pediatric Stem Cell Transplant Recipients: A Feasibility Study

The purpose of this feasibility study is to test the potential for successful implementation of an intervention designed to study the effect of six hours out of bed time on the overall level of deconditioning in pediatric stem cell transplant (SCT) patients. Previous research has demonstrated that deconditioning occurs rapidly over the course of the hospitalization post-transplant and can negatively impact quality of life. By encouraging patients to be out of bed for six hours each day, it is anticipated that patients will experience less deconditioning than those patients who previously had no established minimum time out of the bed.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • St. Louis, Missouri, United States, 63110
        • Washington University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria (Pediatric Patients)

  • Ages 7-17 years
  • Admitted to hospital for stem cell transplant
  • Speaks English

Inclusion Criteria (Parents of pediatric patients)

  • Parents of children ages 7-17 years
  • Parents of children admitted to hospital for stem cell transplant
  • Speaks English

Exclusion Criteria (Pediatric Patients) -Admitted to transplant unit for autologous stem cell transplant, donor lymphocyte infusions, mesenchymal cell infusions, a second stem cell transplant, graft versus host disease or other complications post stem cell transplant will not be included

Exclusion Criteria (Parents of pediatric patients)

-Parents of children admitted to transplant unit for autologous stem cell transplant, donor lymphocyte infusions, mesenchymal cell infusions, a second stem cell transplant, graft versus host disease or other complications post stem cell transplant will not be included

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1: Pediatric patients
  • Patients will wear a Fitbit Flex during hospitalization
  • Completion of Demographic Data Form at baseline, discharge from hospital, and at the six week clinic visit
  • Assist in recording time out of bed using the SCT Daily Activity Log
  • Fill out (some with help of parents) applicable questionnaires: Child Health Ratings Inventories-General Health Module (5-12 years), General Health Module-Baseline Adolescent-Self Report (13-18 years), General Health Module-Follow Up Adolescent-Self Report (13-18 years) at baseline, discharge from hospital, and at six week clinic visit
  • Patients will be assessed using standard physical therapy assessment tools to determine functioning, muscle strength, endurance, and mobility: The Functional Independence Measure for Children and Manual Muscle Testing is done weekly, discharge from hospital, and at six week clinic visit. The 3-Minute Step Test is done at admission, discharge from hospital, and at six week clinic visit.
  • 38 question questionnaire
  • Answers range from 1=all of the time to 5=none of the time
  • 38 question questionnaire about child
  • Answers range from 1=all of the time to 5=none of the time
-16 questions about demographics such as household income, race, and gender
  • Uses Fitbit Flex
  • Log that lists time in 15 minute increments and allows for checking when out of bed and describing the activity that occurred while out of bed
  • 18-item, 7-level ordinal scale instrument that measures a child's consistent performance in essential daily functional skills. Three main domains (selfcare, mobility, and cognition) are assessed by interviewing or by observing a child's performance of a task to criterion standards
  • Categorized into 2 main functional streams: "Dependent" (ie, requires helper: scores 1-5) and "Independent" (ie, requires no helper: scores 6-7). Scores 1 (total assistance) and 2 (maximal assistance) belongs to the "Complete Dependence" category. Scores 3 (moderate assistance), 4 (minimal contact assistance), and 5 (supervision or set-up) belongs to the "Modified Dependence" category. Scores 6 (modified independence) and 7 (complete independence) belongs to the "Independent" category.
Other Names:
  • WeeFIM
-Isometric muscle strength is tested in specific positions, usually with the muscle at an optimal working length. Using a "break" test, the test giver overpowers the muscle being tested to determine the muscle grade.
Other Names:
  • MMT
  • Using an aerobic step, the participant walks up and down for a given amount of time with the heart rate being checked before and after
  • Using the difference in heart rate and a shortness of breath scale, this test is able to give an estimate of aerobic tolerance
  • 7 question questionnaire about child
  • Answers range from 1=all of the time to 5=none of the time
  • 10 question questionnaire about child
  • Answers range from 1=all of the time to 5=none of the time
Experimental: Arm 2: Parents of pediatric patients
  • Parents will be considered participants as they will be completing study questionnaires.
  • Completion of Demographic Data Form at baseline
  • Assist in recording time out of bed using the SCT Daily Activity Log
  • Fill out applicable questionnaires: General Health Module-Baseline Parent Report -Adolescent (13-18 Years), General Health Module-Follow Up Parent Report-Adolescent (13-18 years), General Health Module-Baseline Parent Report-School Age (5-12 years), and General Health Module Follow Up Parent Report-School Age (5-12 years), HSCT Module-Follow UP Parent Report School Age (5-12 years), HSCT Module-Follow Up Parent Report Adolescent (13-18 years), HSCT Module-Follow Up Adolescent-Self Report (13-18 years), HSCT Module-Follow Child-Self Report (5-12 years) at baseline, discharge from hospital, and at six week clinic visit.
  • Assist child with Child Health Ratings Inventories-General Health Module (5-12 years) at baseline, discharge at hospital, and at six week clinic visit
-16 questions about demographics such as household income, race, and gender
  • Uses Fitbit Flex
  • Log that lists time in 15 minute increments and allows for checking when out of bed and describing the activity that occurred while out of bed
  • 38 question questionnaire about child
  • 49 question questionnaire about parent
  • Answers range from 1-all of the time to 5=none of the time
  • 38 question questionnaire about child
  • 49 question questionnaire about parent
  • Answers range from 1-all of the time to 5=none of the time
  • 34 question questionnaire about child
  • 49 question questionnaire about parent
  • Answers range from 1-all of the time to 5=none of the time
  • 34 question questionnaire about child
  • 49 question questionnaire about parent
  • Answers range from 1-all of the time to 5=none of the time
  • 7 question questionnaire about child
  • 49 question questionnaire about parent
  • Answers range from 1=all of the time to 5=none of the time
  • 7 question questionnaire about child
  • 49 question questionnaire about parent
  • Answers range from 1=all of the time to 5=none of the time

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment and retention of participants throughout the study
Time Frame: Baseline through 6 week clinic visit (up to an estimated 82 days)
-Analyze the number of participants enrolled who continue through the 6 week clinic visit
Baseline through 6 week clinic visit (up to an estimated 82 days)
Number of participants who achieve 6 hours out of bed through the 6 week clinic visit
Time Frame: Baseline through 6 week clinic visit (up to an estimated 82 days)
Baseline through 6 week clinic visit (up to an estimated 82 days)
Quality of life as measured by General Health Module questionnaires
Time Frame: Discharge from hospital (estimated to be 40 days)
Discharge from hospital (estimated to be 40 days)
Quality of life as measured by General Health Module questionnaires
Time Frame: Baseline through 6 week clinic visit (up to an estimated 82 days)
Baseline through 6 week clinic visit (up to an estimated 82 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heather Taylor, RN, BSN, CPHON, Washington University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

November 12, 2015

First Submitted That Met QC Criteria

November 18, 2015

First Posted (Estimate)

November 20, 2015

Study Record Updates

Last Update Posted (Estimate)

May 27, 2016

Last Update Submitted That Met QC Criteria

May 26, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 201406031

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hematopoietic and Stem Cell Transplant

Subscribe